BeStock  
Stocks › Oil & Gas E&P › CRC

California Resources CRC

US equityMarket cap rank #2151Oil & Gas E&P
$53.01 +$0.58 (+1.11%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $53.01 0.00%
Open$52.30
Prev close$52.43
Day range$51.55 – $53.69
Volume736.1K
Market cap$4.71B
P/E (TTM)–
Dividend yield3.02%

CRC Stock News

Headlines matching California Resources or the CRC ticker, most recent first.

  • Central Retail Corp. Target Price Raised to THB36.00 From THB31.00 by Ttb Wealth Securities CRC.THDow Jones · 8 Sep 2026
  • UBS Maintains California Resources(CRC.US) With Buy Rating, Maintains Target Price $73Market news · 28 Sep 2026
  • Roth MKM Maintains California Resources(CRC.US) With Buy RatingMarket news · 25 Sep 2026
  • Roth MKM Maintains California Resources(CRC.US) With Buy Rating, Maintains Target Price $59Market news · 18 Sep 2026
  • Stifel Initiates California Resources(CRC.US) With Buy Rating, Announces Target Price $68Market news · 18 Sep 2026
  • Stephens Maintains California Resources(CRC.US) With Buy Rating, Raises Target Price to $91Market news · 18 Sep 2026
  • Roth MKM Maintains California Resources(CRC.US) With Buy Rating, Raises Target Price to $59Market news · 17 Sep 2026
  • RBC Capital Maintains California Resources(CRC.US) With Buy Rating, Maintains Target Price $77Market news · 15 Sep 2026
  • UBS Maintains California Resources(CRC.US) With Buy Rating, Raises Target Price to $73Market news · 14 Sep 2026
  • RBC Capital Maintains California Resources(CRC.US) With Buy Rating, Cuts Target Price to $77Market news · 22 Aug 2026
  • Central Retail Corp. Target Price Raised to THB33.00 From THB31.00 by UOB Kay Hian CRC.THDow Jones · 21 Aug 2026
  • Barclays Maintains California Resources(CRC.US) With Buy Rating, Cuts Target Price to $74Market news · 17 Aug 2026
  • J.P. Morgan Maintains California Resources(CRC.US) With Buy Rating, Raises Target Price to $79Market news · 13 Aug 2026
  • J.P. Morgan Keeps Their Buy Rating on California Resources Corp (CRC)TipRanks · 13 Aug 2026
  • TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-TRANSCENTA'S PARTNER INHIBRX REPORTSPOSITIVE UPDATED CRC DATA FOR OZEKIBART ANDANNOUNCES U.S. BLA SUBMISSION FOR CHONDROSARCOMAHKEX · 21 May 2026

Discussion

No comments yet — be the first to weigh in on CRC.

Leave a comment

Scroll to Top